The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Lene Holmvang
Showing 1-16 of 16 articles
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial
Lansky AJ,
Xu B,
Baumbach A,
Kelbæk H,
van Royen N,
Zheng M,
Knaapen P,
Slagboom T,
Johnson TW,
Vlachojannis GJ,
Arkenbout KE,
Holmvang L,
Janssens L,
Brugaletta S,
Naber CK,
Schmitz T,
Anderson R,
Rittger H,
Berti S,
Barbato E,
Toth GG,
Maillard L,
Valina CM,
Buszman PE,
Thiele H,
Schächinger V,
Wijns W
December 4, 2023 | 10.4244/EIJ-D-23-00409
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Heart Rhythm Association (EHRA), the European Association of Cardiovascular Imaging (EACVI), the ESC Regulatory Affairs Committee and Women as One
Manzo-Silberman S,
Velázquez M,
Burgess S,
Sahni S,
Best P,
Mehran R,
Piccaluga E,
Vitali-Serdoz L,
Sarma A,
Barbash I,
Mauri J,
Szymański P,
Hinterbuchner L,
Stefanini G,
Gimelli A,
Maurovich-Horvat P,
Boersma L,
Buchanan G,
Pontone G,
Holmvang L,
Karam N,
Neylon A,
Morice M,
Leclercq C,
Tarantini G,
Dudek D,
Chieffo A
May 12, 2023 | 10.4244/EIJ-D-22-00407
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M,
Olsen N,
Holmvang L,
Tilsted H,
Pedersen F,
Joshi F,
Sørensen R,
Jabbari R,
Arslani K,
Sondergaard L,
Engstrøm T,
Lønborg J
February 20, 2023 | 10.4244/EIJ-D-22-00621
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention
Madsen J,
Kelbæk H,
Nepper-Christensen L,
Jacobsen M,
Ahtarovski KA,
Høfsten D,
Holmvang L,
Pedersen F,
Tilsted H,
Aarøe J,
Jensen SE,
Raungaard B,
Terkelsen CJ,
Køber L,
Engstrøm T,
Lønborg J
August 19, 2022 | 10.4244/EIJ-D-21-00950
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter R,
Hamm C,
Steg G,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Myocardial damage after ST-segment elevation myocardial infarction by use of bivalirudin or heparin: a DANAMI-3 substudy
Schoos M,
Nepper-Christensen L,
Ahtarovski KA,
Kyhl K,
Göransson C,
Holmvang L,
Kelbæk H,
Helqvist S,
Høfsten D,
Køber L,
Vejlstrup N,
Lønborg J,
Engstrøm T
April 3, 2020 | 10.4244/EIJ-D-19-00623
Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy
De Backer O,
Lønborg J,
Helqvist S,
Warnøe J,
Kløvgaard L,
Holmvang L,
Pedersen F,
Tilsted H,
Raungaard B,
Jørgensen E,
Køber L,
Høfsten D,
Kelbæk H,
Engstrøm T
June 20, 2019 | 10.4244/EIJ-D-18-00766
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy
Nepper-Christensen L,
Lønborg J,
Hofsten D,
Ahtarovski KA,
Kyhl K,
Göransson C,
Køber L,
Helqvist S,
Pedersen F,
Kelbæk H,
Vejlstrup N,
Holmvang L,
Engstrøm T
August 24, 2018 | 10.4244/EIJ-D-17-00857
The effect of TIcagrelor administered through a nasogastric tube to COMAtose patients undergoing acute percutaneous coronary intervention: the TICOMA study
Ratcovich H,
Sadjadieh G,
Andersson H,
Frydland M,
Wiberg S,
Dridi N,
Kjaergaard J,
Holmvang L
February 20, 2017 | 10.4244/EIJ-D-16-00398
Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy
Sadjadieh G,
Engstrøm T,
Helqvist S,
Hofsten D,
Køber L,
Pedersen F,
Clemmensen P,
Jørgensen E,
Saunamäki K,
Tilsted H,
Kelbæk H,
Holmvang L
November 20, 2016 | 10.4244/EIJV12I10A203
A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction
Kyhl K,
Lønborg J,
Vejlstrup N,
Kelbæk H,
Helqvist S,
Holmvang L,
Jørgensen E,
Saunamäki K,
Bøtker H,
Clemmensen P,
Køber L,
Treiman M,
Engstrøm T
July 20, 2016 | 10.4244/EIJV12I4A78
Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis
De Backer O,
Biasco L,
Lønborg J,
Pedersen F,
Holmvang L,
Kelbæk H,
Arnous S,
Saunamäki K,
Helqvist S,
Kastrup J,
Jørgensen E,
Engstrøm T
February 12, 2016 | 10.4244/EIJV11I11A247
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions
Kelbæk H,
Holmvang L,
Richardt G,
Eberli F,
Stella P,
Buszman P,
Neumann F,
Serruys P,
Windecker S,
Widimský P,
Belardi J,
Silber S
October 20, 2015 | 10.4244/EIJY14M07_14
Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction
Schoos M,
Pedersen F,
Holmvang L,
Engstrøm T,
Saunamäki K,
Helqvist S,
Kastrup J,
Mehran R,
Dangas G,
Jørgensen E,
Kelbæk H,
Clemmensen P
September 22, 2015 | 10.4244/EIJY14M11_07
ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction
Lønborg J,
Kelbæk H,
Engstrøm T,
Helqvist S,
Kløvgaard L,
Holmvang L,
Vejlstrup N,
Jørgensen E,
Saunamäki K,
Dridi N,
Kaltoft A,
Bøtker H,
Clemmensen P,
Terkelsen CJ
August 19, 2014 | 10.4244/EIJV10I4A80
Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study
Kelbæk H,
Engstrøm T,
Ahtarovski KA,
Lønborg J,
Vejlstrup N,
Pedersen F,
Holmvang L,
Helqvist S,
Saunamäki K,
Jørgensen E,
Clemmensen P,
Kløvgaard L,
Tilsted H,
Raungaard B,
Ravkilde J,
Aaroe J,
Eggert S,
Køber L
February 22, 2013 | 10.4244/EIJV8I10A175
1
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023